Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Return on Assets (2016 - 2025)

Northwest Biotherapeutics' Return on Assets history spans 15 years, with the latest figure at 0.39% for Q4 2025.

  • Quarterly results put Return on Assets at 0.39% for Q4 2025, up 51.0% from a year ago — trailing twelve months through Dec 2025 was 0.39% (up 51.0% YoY), and the annual figure for FY2025 was 1.12%, up 195.0%.
  • Return on Assets for Q4 2025 was 0.39% at Northwest Biotherapeutics, up from 0.82% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.39% in Q4 2025 to a low of 3.67% in Q2 2021.
  • The 5-year median for Return on Assets is 2.13% (2023), against an average of 1.94%.
  • The sharpest move saw Return on Assets tumbled -103bps in 2021, then skyrocketed 186bps in 2022.
  • Year by year, Return on Assets stood at 1.69% in 2021, then crashed by -39bps to 2.35% in 2022, then grew by 13bps to 2.05% in 2023, then soared by 56bps to 0.9% in 2024, then surged by 57bps to 0.39% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.39%, 0.82%, and 0.86% for Q4 2025, Q3 2025, and Q2 2025 respectively.